Arnold Hanish Acquires Shares in Omeros Corporation
Arnold Hanish bought 15,000 shares of Omeros Corporation on June 18, 2026.
Key Points
- Arnold Hanish purchased 15,000 shares of Omeros Corporation on June 18, 2026, with the transaction not being part of a planned program.
- Omeros Corporation, trading around $10.28, has a market cap of $744 million and a P/E ratio of 9.0.
- Institutional investors like BlackRock and Vanguard have increased their holdings in Omeros Corporation recently.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Arnold Hanish, an insider at Omeros Corporation, purchased 15,000 shares of the company on June 18, 2026. This buy was not part of a pre-planned trading program. The transaction details, such as the price paid per share, were not disclosed.
Other Institutional Activity in Omeros Corporation
Several institutional investors have shown interest in Omeros Corporation. BlackRock, Inc. increased its holdings by 247,188 shares, bringing its total to 5,309,626 shares worth about $56.1 million. Ingalls & Snyder LLC also grew its position by 110,724 shares, holding 3,559,423 shares valued at approximately $37.6 million. Vanguard Capital Management LLC opened a new position with 2,983,259 shares, valued at $31.5 million. UBS Group AG added 117,749 shares, totaling 2,340,731 shares worth $24.7 million. State Street Corp significantly increased its stake by 346,049 shares, now holding 1,919,575 shares valued at $20.3 million.
Omeros Corporation Stock Down 44.5%
Shares of NasdaqGM:OMER traded near $10.28 on Monday. Omeros Corporation has a market cap of $744 million and a P/E ratio of 9.0. The stock has a 52-week low of $2.95 and a high of $17.65. Its 50-day moving average is $12.22, and the 200-day moving average is $10.11. The company has a current ratio of 3.03 and a quick ratio of 2.48, indicating strong liquidity.
$OMER stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Omeros Corporation reported revenue of $9.89 million. The company has a net margin of 8.7% and an EPS of $1.14. Its next earnings release is scheduled for August 13, 2026.
Insider Buying and Selling at Omeros Corporation
On June 18, 2026, several insiders, including Leroy Hood, Diana Perkinson, Rajiv Shah, Thomas Bumol, Arnold Hanish, and Peter Demopulos, each purchased 15,000 shares of Omeros Corporation. None of these transactions were part of a pre-planned trading program.
Analysts Set New Price Targets
On April 21, 2026, D. Boral Capital maintained its 'buy' rating for Omeros Corporation with a price target of $36. HC Wainwright & Co. also maintained a 'buy' rating, setting a target of $40. The consensus among analysts is a 'buy' recommendation, with a mean target price of $40.
About Omeros Corporation
Omeros Corporation, headquartered in Seattle, WA, is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. Its lead product candidate, Narsoplimab, targets immunologic diseases like hematopoietic stem-cell transplant-associated thrombotic microangiopathy. Omeros also develops treatments for lectin pathway disorders and compulsive disorders, among others. The company is led by CEO Dr. Gregory A. Demopulos and employs about 175 people.
Bottom Line
Arnold Hanish's recent purchase of Omeros Corporation shares highlights ongoing insider confidence in the company. Investors keep a close eye on insider transactions as they can signal potential future performance. It's important to note that such filings reflect past actions and may not indicate current positions.
Get Omeros Corporation alerts
New 13F filings, insider trades, and analyst moves on $OMER, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.